Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
62.48
-2.70 (-4.14%)
At close: May 15, 2026, 4:00 PM EDT
61.00
-1.48 (-2.37%)
After-hours: May 15, 2026, 5:00 PM EDT
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 370 employees as of December 31, 2025. The number of employees increased by 47 or 14.55% compared to the previous year.
Employees
370
Change (1Y)
47
Growth (1Y)
14.55%
Revenue / Employee
$1,446,159
Profits / Employee
-$130,446
Market Cap
2.69B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 370 | 47 | 14.55% |
| Dec 31, 2024 | 323 | 79 | 32.38% |
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Vera Therapeutics | 249 |
| Alumis | 224 |
| Structure Therapeutics | 220 |
| Soleno Therapeutics | 182 |
| Disc Medicine | 154 |
TARS News
- 2 days ago - Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans - GlobeNewsWire
- 3 days ago - Tarsus Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Tarsus Pharmaceuticals reports Q1 EPS (16c), consensus (40c) - TheFly
- 9 days ago - Tarsus Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 9 days ago - Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements - GlobeNewsWire
- 16 days ago - Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 - GlobeNewsWire
- 22 days ago - Tarsus Pharmaceuticals assumed with an Outperform at Oppenheimer - TheFly